Related references
Note: Only part of the references are listed.Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes
Chin-Hsiao Tseng
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Obesity-Associated Alterations in Inflammation, Epigenetics, and Mammary Tumor Growth Persist in Formerly Obese Mice
Emily L. Rossi et al.
CANCER PREVENTION RESEARCH (2016)
A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk
Ruth C. Travis et al.
CANCER RESEARCH (2016)
Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals
Jonathan N. Hofmann et al.
CANCER RESEARCH (2016)
Obesity and Cancer: The Oil that Feeds the Flame
Joan Font-Burgada et al.
CELL METABOLISM (2016)
High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with ∼240-Fold Higher Drug Concentration in Urine than Serum
Zhongbo Liu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Pioglitazone use and risk of bladder cancer: population based cohort study
Marco Tuccori et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Neil Murphy et al.
PLOS MEDICINE (2016)
Pioglitazone use and risk of bladder cancer: population based cohort study
Marco Tuccori et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Obesity and Cancer: Local and Systemic Mechanisms
Neil M. Iyengar et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
Pauline A. J. Vissers et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
Sirwan M. Hadad et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
C. M. Nagle et al.
BRITISH JOURNAL OF CANCER (2015)
Pre-existing diabetes and breast cancer prognosis among elderly women
J. Luo et al.
BRITISH JOURNAL OF CANCER (2015)
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials
E. Geuna et al.
BRITISH JOURNAL OF CANCER (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect
G. Ariaans et al.
CANCER TREATMENT REVIEWS (2015)
GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7
Jacqueline A. Koehler et al.
CELL METABOLISM (2015)
Pharmacological Inhibition of PI3K Reduces Adiposity and Metabolic Syndrome in Obese Mice and Rhesus Monkeys
Ana Ortega-Molina et al.
CELL METABOLISM (2015)
Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome
Siegfried Ussar et al.
CELL METABOLISM (2015)
Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade
Wade T. Iams et al.
CLINICAL CANCER RESEARCH (2015)
Drugging PI3K in cancer: refining targets and therapeutic strategies
Timothy A. Yap et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes
Marco Tuccori et al.
DIABETES CARE (2015)
Incretin-Based Drugs and Adverse Pancreatic Events: Almost a Decade Later and Uncertainty Remains
Laurent Azoulay
DIABETES CARE (2015)
mTOR inhibitors and diabetes
Bruno Verges et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
Alan J. Garber et al.
ENDOCRINE PRACTICE (2015)
Obesity and cancer: mechanistic insights from transdisciplinary studies
Emma H. Allott et al.
ENDOCRINE-RELATED CANCER (2015)
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
James D. Lewis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration
Emanuele Di Angelantonio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis
Mary C. Playdon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes et al.
LANCET ONCOLOGY (2015)
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Melina Arnold et al.
LANCET ONCOLOGY (2015)
PROSTATE CANCER 4 BIG QUESTIONS
Richard Hodson
NATURE (2015)
Neutrophil ageing is regulated by the microbiome
Dachuan Zhang et al.
NATURE (2015)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
BLADDER CANCER Pioglitazone-when is a prescription drug safe?
Yoon Kong Loke et al.
NATURE REVIEWS UROLOGY (2015)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK
Bernd Kowall et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
OBESITY AND DIABETES: THE INCREASED RISK OF CANCER AND CANCER-RELATED MORTALITY
Emily Jane Gallagher et al.
PHYSIOLOGICAL REVIEWS (2015)
The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Madhur Nayan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo
Ping Yang et al.
SCIENTIFIC REPORTS (2015)
Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies
Lang Wu et al.
SCIENTIFIC REPORTS (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care
Ian J. Douglas et al.
PLOS MEDICINE (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis
Mary C. Playdon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials
Marian L. Neuhouser et al.
JAMA ONCOLOGY (2015)
Cancer and bone fractures in observational follow-up of the RECORD study
Nigel P. Jones et al.
ACTA DIABETOLOGICA (2015)
Obesity and the outcome of young breast cancer patients in the UK: the POSH study
E. R. Copson et al.
ANNALS OF ONCOLOGY (2015)
Diabetes and Other Comorbidities in Breast Cancer Survival by Race/Ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC)
Anna H. Wu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors
Igor Puzanov et al.
CLINICAL CANCER RESEARCH (2015)
Are Sulfonylurea and Insulin Therapies Associated With a Larger Risk of Cancer Than Metformin Therapy? A Retrospective Database Analysis
Bernd Kowall et al.
DIABETES CARE (2015)
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
Daniel Levin et al.
DIABETOLOGIA (2015)
Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
Cecilia Bosco et al.
PLOS ONE (2015)
Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance
Seon-Yeong Lee et al.
PLOS ONE (2015)
Adiposity and cancer risk: new mechanistic insights from epidemiology
Andrew G. Renehan et al.
NATURE REVIEWS CANCER (2015)
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial
Peter Widschwendter et al.
BREAST CANCER RESEARCH (2015)
Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence
Heleen K. Bronsveld et al.
BREAST CANCER RESEARCH (2015)
Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity
B. Nellemann et al.
ACTA PHYSIOLOGICA (2014)
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies
D. S. M. Chan et al.
ANNALS OF ONCOLOGY (2014)
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Andrea DeCensi et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Type 2 diabetes and the risk of mortality among patients with prostate cancer
Leah Bensimon et al.
CANCER CAUSES & CONTROL (2014)
The Use of Metformin in Patients with Prostate Cancer and the Risk of Death
Leah Bensimon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini et al.
CANCER PREVENTION RESEARCH (2014)
Pancreatic Safety of Newer Incretin-Based Therapies: Are the -tides Finally Turning?
Sridevi Devaraj et al.
DIABETES (2014)
Androgen Receptor Roles in Insulin Resistance and Obesity in Males: The Linkage of Androgen-Deprivation Therapy to Metabolic Syndrome
I-Chen Yu et al.
DIABETES (2014)
Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
Ronac Mamtani et al.
DIABETES CARE (2014)
Metformin Does Not Affect Cancer Risk: A Cohort Study in the UK Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
Konstantinos K. Tsilidis et al.
DIABETES CARE (2014)
The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia
Louise Bordeleau et al.
DIABETES CARE (2014)
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study
M. Gokhale et al.
DIABETES OBESITY & METABOLISM (2014)
The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
Z. -J. Zhang et al.
DIABETES OBESITY & METABOLISM (2014)
Global estimates of diabetes prevalence for 2013 and projections for 2035
L. Guariguata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Prostate Cancer, Prostate Cancer Death, and Death from Other Causes, Among Men with Metabolic Aberrations
Christel Haggstrom et al.
EPIDEMIOLOGY (2014)
Adult Life after Childhood Cancer in Scandinavia: Diabetes mellitus following treatment for cancer in childhood
Anna Sallfors Holmqvist et al.
EUROPEAN JOURNAL OF CANCER (2014)
Androgen-deprivation Therapy and Diabetes Control Among Diabetic Men with Prostate Cancer
Nancy L. Keating et al.
EUROPEAN UROLOGY (2014)
Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial
Brian I. Rini et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Risk of Diabetes Mellitus in Long-Term Survivors of Hodgkin Lymphoma
Frederika A. van Nimwegen et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Obesity and Cardiovascular Diseases
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013
Marie Ng et al.
LANCET (2014)
Repurposing biguanides to target energy metabolism for cancer treatment
Michael Pollak
NATURE MEDICINE (2014)
EPIDEMIOLOGY Obesity and cancer-the evidence is fattening up
Rudolf Kaaks et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Pancreatic Safety of Incretin-Based Drugs - FDA and EMA Assessment
Amy G. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Ajay K. Gopal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer cachexia: understanding the molecular basis
Josep M. Argiles et al.
NATURE REVIEWS CANCER (2014)
IGF binding proteins in cancer: mechanistic and clinical insights
Robert C. Baxter
NATURE REVIEWS CANCER (2014)
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database
E. Raschi et al.
ACTA DIABETOLOGICA (2013)
Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-B activation
Olga Moiseeva et al.
AGING CELL (2013)
Obesity paradox: Differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus
Chin-Hsiao Tseng
ATHEROSCLEROSIS (2013)
Molecular Pathways: Adiponectin and Leptin Signaling in Cancer
Michael N. VanSaun
CLINICAL CANCER RESEARCH (2013)
The high incidence of steroid-induced hyperglycaemia in hospital
Ashley C. Fong et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Influence of glucocorticoids and growth hormone on insulin sensitivity in humans
K. C. J. Yuen et al.
DIABETIC MEDICINE (2013)
Cancer detection rates following enrolment in a disease management programme for type 2 diabetes
A. S. Geier et al.
DIABETOLOGIA (2013)
MANAGEMENT OF HYPERGLYCEMIA IN DIABETIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES DURING DEXAMETHASONE THERAPY
Aidar R. Gosmanov et al.
ENDOCRINE PRACTICE (2013)
Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?
Nancy L. Keating et al.
EUROPEAN UROLOGY (2013)
Obesity and incidence of lung cancer: A meta-analysis
Yang Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Metformin Use and All-Cause and Prostate Cancer-Specific Mortality Among Men With Diabetes
David Margel et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts
Ying Bao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
An Epidemiologic and Genomic Investigation Into the Obesity Paradox in Renal Cell Carcinoma
A. Ari Hakimi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2:ERG
Andreas Pettersson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Hyperglycemia, Insulin Resistance, Impaired Pancreatic -Cell Function, and Risk of Pancreatic Cancer
Brian M. Wolpin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Glucocorticoids and Insulin Resistance in Children With Acute Lymphoblastic Leukemia
Eric J. Chow et al.
PEDIATRIC BLOOD & CANCER (2013)
The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Gitanjali M. Singh et al.
PLOS ONE (2013)
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Vanessa K. Ridaura et al.
SCIENCE (2013)
On-target Effects of GLP-1 Receptor Agonists on Thyroid C-cells in Rats and Mice
Thomas J. Rosol
TOXICOLOGIC PATHOLOGY (2013)
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+breast cancer
X. He et al.
ANNALS OF ONCOLOGY (2012)
A prospective study of circulating adipokine levels and risk of multiple myeloma
Jonathan N. Hofmann et al.
BLOOD (2012)
The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality
Danny R. Youlden et al.
CANCER EPIDEMIOLOGY (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
T. P. van Staa et al.
DIABETOLOGIA (2012)
Cancer occurrence in Danish diabetic patients: duration and insulin effects
B. Carstensen et al.
DIABETOLOGIA (2012)
Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
Chia-Hsuin Chang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it
Heather A. Ferris et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway
Naifa L. Busaidy et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity
Aparna Pal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
Iris L. Romero et al.
OBSTETRICS AND GYNECOLOGY (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
Laurent Azoulay et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Long-Term Risk of Incident Type 2 Diabetes and Measures of Overall and Regional Obesity: The EPIC-InterAct Case-Cohort Study
Claudia Langenberg et al.
PLOS MEDICINE (2012)
The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
Jennifer H. Gunter et al.
ADVANCES IN UROLOGY (2012)
Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells
Amy A. Lubik et al.
CANCER RESEARCH (2011)
Diabetes and Risk of Prostate Cancer A study using the National Health Insurance
Chin-Hsiao Tseng
DIABETES CARE (2011)
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study
James D. Lewis et al.
DIABETES CARE (2011)
IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer
Carly Jade Dool et al.
ENDOCRINE-RELATED CANCER (2011)
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies
Michael Elashoff et al.
GASTROENTEROLOGY (2011)
Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
Kimberly S. Peairs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy
Beatrice Waser et al.
NEUROENDOCRINOLOGY (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Diabetes in Cushing syndrome: basic and clinical aspects
Gherardo Mazziotti et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
A systematic review and meta-analysis of the relationship between body size and testicular cancer
C. C. Lerro et al.
BRITISH JOURNAL OF CANCER (2010)
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
Paul Haluska et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis
Kelly B. Stein et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2010)
Body-Mass Index and Mortality among 1.46 Million White Adults.
Amy Berrington de Gonzalez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Regulation of Insulin-like Growth Factor-I in Starvation and Injury
Jean-Paul Thissen et al.
NUTRITION REVIEWS (2010)
Does pre-existing diabetes affect prostate cancer prognosis? A systematic review
C. F. Snyder et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Diabetes Mellitus in Long-term Survivors of Childhood Cancer Increased Risk Associated With Radiation Therapy: A Report for the Childhood Cancer Survivor Study
Lillian R. Meacham et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Do Cancer Cells Care If Their Host Is Hungry?
Michael Pollak
CELL METABOLISM (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer
Tomasz P. Srokowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hyperglycemia during Induction Therapy is Associated with Poorer Survival in Children with Acute Lymphocytic Leukemia
Rona Y. Sonabend et al.
JOURNAL OF PEDIATRICS (2009)
Insulin glargine and malignancy: an unwarranted alarm
Stuart J. Pocock et al.
LANCET (2009)
Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial
Lars Sjostrom et al.
LANCET ONCOLOGY (2009)
The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
Mahvash Zakikhani et al.
CANCER PREVENTION RESEARCH (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
Jing Ma et al.
LANCET ONCOLOGY (2008)
Proliferative effects of insulin analogues on mammary epithelial cells
Doris Mayer et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
Gillian K. Reeves et al.
BRITISH MEDICAL JOURNAL (2007)
Long-term mortality after gastric bypass surgery
Ted D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Adult weight change and risk of postmenopausal breast cancer
AH Eliassen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men
DE Laaksonen et al.
DIABETES CARE (2004)
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes
S Dhindsa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women
TJ Key et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study
ED Parker et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Sulfonylurea stimulation of insulin secretion
P Proks et al.
DIABETES (2002)
The contribution of fat and fat-free tissue to body mass index in contemporary children and the reference child
JCK Wells et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
